Suppr超能文献

非心脏手术围手术期低血压与血管活性药物的应用:范围综述。

Perioperative hypotension and use of vasoactive agents in non-cardiac surgery: A scoping review.

机构信息

Department of Anaesthesiology and Intensive Care, Holbæk Hospital, Holbæk, Denmark.

Department of Anaesthesiology and Intensive Care, Zealand University Hospital, Køge, Denmark.

出版信息

Acta Anaesthesiol Scand. 2024 Oct;68(9):1134-1148. doi: 10.1111/aas.14485. Epub 2024 Jul 4.

Abstract

BACKGROUND

Perioperative hypotension is common and associated with adverse patient outcomes. Vasoactive agents are often used to manage hypotension, but the ideal drug, dose and duration of treatment has not been established. With this scoping review, we aim to provide an overview of the current body of evidence regarding the vasoactive agents used to treat perioperative hypotension in non-cardiac surgery.

METHODS

We included all studies describing the use of vasoactive agents for the treatment of perioperative hypotension in non-cardiac surgery. We excluded literature reviews, case studies, and studies on animals and healthy subjects. We posed the following research questions: (1) in which surgical populations have vasoactive agents been studied? (2) which agents have been studied? (3) what doses have been assessed? (4) what is the duration of treatment? and (5) which desirable and undesirable outcomes have been assessed?

RESULTS

We included 124 studies representing 10 surgical specialties. Eighteen different agents were evaluated, predominantly phenylephrine, ephedrine, and noradrenaline. The agents were administered through six different routes, and numerous comparisons between agents, dosages and routes were included. Then, 88 distinct outcome measures were assessed, of which 54 were judged to be non-patient-centred.

CONCLUSIONS

We found that studies concerning vasoactive agents for the treatment of perioperative hypotension varied considerably in all aspects. Populations were heterogeneous, interventions and exposures included multiple agents compared against themselves, each other, fluids or placebo, and studies reported primarily non-patient-centred outcomes.

摘要

背景

围手术期低血压很常见,与患者不良结局相关。血管活性药物常被用于治疗低血压,但尚未确定理想的药物、剂量和治疗持续时间。本范围综述旨在概述目前关于用于治疗非心脏手术围手术期低血压的血管活性药物的证据。

方法

我们纳入了所有描述血管活性药物治疗非心脏手术围手术期低血压的研究。我们排除了文献综述、病例研究以及动物和健康受试者的研究。我们提出了以下研究问题:(1)血管活性药物在哪些手术人群中进行了研究?(2)哪些药物进行了研究?(3)评估了哪些剂量?(4)治疗持续时间是多久?(5)评估了哪些理想和不理想的结局?

结果

我们纳入了代表 10 个外科专业的 124 项研究。评估了 18 种不同的药物,主要是去氧肾上腺素、麻黄碱和去甲肾上腺素。药物通过六种不同途径给药,包括许多药物之间、剂量之间和途径之间的比较。然后,评估了 88 个不同的结局指标,其中 54 个被认为是非患者中心的。

结论

我们发现,关于血管活性药物治疗围手术期低血压的研究在各个方面差异很大。人群具有异质性,干预措施和暴露包括多种药物与自身、彼此、液体或安慰剂进行比较,且研究主要报告非患者中心的结局。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验